Annexon, Inc. (ANNX)
NASDAQ: ANNX · Real-Time Price · USD
5.29
+0.03 (0.57%)
At close: Aug 14, 2026, 4:00 PM EDT
5.39
+0.10 (1.89%)
After-hours: Aug 14, 2026, 7:56 PM EDT
Annexon Market Cap
Annexon has a market cap or net worth of $1 billion as of August 14, 2026. Its market cap has increased by 251.57% in one year.
Market Cap
1.00B
Enterprise Value
818.28M
1-Year Change
251.57%
Ranking
Category
Stock Price
$5.29
ChartMarket Cap Chart
Since July 24, 2020, Annexon's market cap has increased from $639.51M to $1.00B, an increase of 56.82%. That is a compound annual growth rate of 7.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 1.00B | 34.03% |
| Dec 31, 2025 | 748.26M | 36.84% |
| Dec 31, 2024 | 546.82M | 53.75% |
| Dec 29, 2023 | 355.65M | 44.43% |
| Dec 30, 2022 | 246.25M | -44.15% |
| Dec 31, 2021 | 440.93M | -53.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wave Life Sciences | 1.07B |
| Sana Biotechnology | 1.06B |
| Inventiva | 1.06B |
| Avalo Therapeutics | 1.05B |
| Lexicon Pharmaceuticals | 1.03B |
| Ardelyx | 1.01B |
| Odyssey Therapeutics | 993.35M |
| Solid Biosciences | 986.47M |